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Many ideas about metabolic processes have developed from measurements of arteriovenous concentration differences across tissues (1) (2) (3) (4) (5) . This inter-organ exchange involves plasma as well as erythrocytes (6) (7) (8) (9) . However, the concentrations of metabolites in erythrocytes may differ substantially from those in plasma (6, 7) (e.g., folate, glutamate, and glutathione), and in some circumstances erythrocytes may play a bigger role than plasma in the exchange of substrates between blood and tissues (6). Therefore, to assess the flux of metabolites across individual tissues or organs, one must relate the blood flow to a tissue to the arteriovenous concentration difference of metabolites in whole blood.
The biochemical analysis of metabolites in whole blood requires initial deproteinization to remove hemoglobin and other proteins that may interfere with the assays. One of the most common agents for this is perchloric acid (10) (11) (12) . However, because perchiorate may inhibit some enzyme reactions considerably, investigators may either remove perchlorate by precipitation with potassium hydroxide, or use it in only small amounts, as in fluorometry (10) (11) (12) (13) (14) (15) . The use of small sample volumes may reduce this inhibition but does not necessarily eliminate it. Therefore, assessment of the concentration of metabolites may give misleading re-suits if the assays are carried out in the presence of various amounts of perchloric acid or other inhibitory substances.
A further disadvantage of using perchloric acid as a deproteinizing agent is that the resulting sample (acid supernate) is not suitable for amino acid analysis by chromatography. Therefore, some workers treat blood samples one way for measuring intermediary metabolites, such as glucose, lactate, and ketone bodies, and another way for measuring amino acids (1, 8, 13-16) .
Here, we suggest a simple procedure involving a single deproteinizing step with 5-sulfosalicylic acid (SSA), which yields a sample that is suitable for both enzymatic determination of metabolites and chromatographic determination of amino acids.
Materials and Methods
The following reagents were obtained from (Table 1 ). In this series of reactions, all assays were performed with standard solutions of metabolites and control samples of both SSA and water. At 344) nm, the wavelength usually used to monitor the progress of NAD/NADH-linked reactions, there is considerable absorbance of SSA (Figure 1) . Therefore, we measured the change in absorbance at 355 mm.
The first absorbance reading was made at the end of a short (2-mm) pro-incubation. A starter enzyme was then added, and the change in absorbance with time was monitored until the reaction was complete. For the glucoseassay, the first reading was obtained 0.5 s after mixing the sample with the buffer-coenzyme-enzyme mixture, during which time the absorbance changed negligibly.
Precision. The intra-and interbatch variations (CVs) of standard metabolite solutions were assessed by assaying a low and a high concentration of each metabolite to encompass the physiological range in whole blood (Table 2). The intrabatch variation was determined by simultaneously analyzing eight samples that had the same concentration of metabolite added to whole blood.
The interbatch variation was assessed by analyzing the same samples in six separate runs.
Analytical recovery. The analytical recovery of metabolites in blood was assessed by adding known amounts of metabolites to whole blood (one volume of metabolite solution to nine volumes of whole blood) and mixing well. The quantities of metabolites added were chosen to increase the normal concentration of metabolites by -'50% and 100%, to the concentrations found in pathophysiological circumstances (n = 5 separate blood samples for each metabolite that had the larger increase in concentration, and one or two separate blood samples for each metabolite that had the smaller increase).
The samples were then mixed and deproteinized as described above, with 35 g/L SSA solution. The precise amounts used were measured gravimetrically with an accurate electronic balance. Aliquots of the acid supernates were then used for analysis.
Stability. Whole blood was deproteinized as described above. The acid supernates were analyzed as soon as possible after sampling, and aliquots were stored in duplicate at 4,20, and -20 #{176}C. All assays were repeated after three days, one week, three weeks, and three months. The effect of repeated freezing and thawing of samples was also investigated, with aliquots of the original SSA-blood extract. These samples were thawed at the same time as those used in stability studies.
Results
The molar absorptivity of NADH at 355 mm was found tobe 5.04 x 105 Lmol1cm1.
Precision and recovery. The results of the intra-and interbatch variation studies are indicated in Table 2 . CVs were all <3%, except the interbatch CV for determinations of 3-hydroxybutyrate at low concentrations, which was 5.4%. The analytical recovery of metabolites added to blood ranged from 96.4% to 103.0% at the higher concentration (Table 3 ). Acetoacetate and 3-hydroxybutyrate had similar recoveries at the lower concentrations (n = 5, Table 3 ); the recovery of the other metabolites at lower concentrations ranged from 96 to 102% (n = 2 for each metabolite; data not shown).
Stability. The results of the stability experiment are shown in Figure 2 and thawing of the SSA-blood extract for short periods had no demonstrable effect on the concentration of metabolites.
Discussion
The reactions for assaying metabolites took between a few seconds (pyruvate assay) and 20 mm (alanine assay). The precision of the glucose assay is similar to that obtained previously (25, 26), but for most of the other assays, the present results are better than those reported by several researchers (25) (26) (27) (28) (29) . Similarly, although the number of samples is small, recoveries of metabolites are as good as, if not better than, those reported by others (25) (26) (27) (28) (29) .
These differences between various laboratories may be attributable to a combination of factors. One factor is (27) (28) (29) instead of the end-point methods used in this study.
The concentrations of glucose, lactate, glutamate, alanine, and 3-hydroxybutyrate were stable when samples were stored at -20 #{176}C for 90 days. Glutanilne and acetoacetate were less stable, to an extent that depended on the storage temperature. The loss was substantially lower at -20 #{176}C than at 4 and 20#{176}C ( Figure  2) . Although temperatures lower than -20 #{176}C may reduce the loss of glutaniine and acetoacetate even further, we suggest that these metabolites should be assayed soon after sampling.
The loss of glutamine was not associated with an increase in the concentration of glutamate, which suggests that glutamine degrades to substances other than Table 2 glutamate, e.g., pyroglutamate (5-oxo-2-pyrrolidine carboxylate).
Using SSA as a deproteinizing agent has four main advantages over using other agents. First, the SSA extract is suitable not only for measuring a variety of metabolites ( Table 1) , but also for directly measuring amino acids by chromatography. Other deproteinizing agents in the quantities commonly used may not be suitable for amino acid analyses: they may either adversely affect the separation of amino acids because of the pH effect or may damage the resin in the column of the amino acid analyzer (e.g., as perchloric acid does). Second, the single precipitation procedure with SSA is simpler than with procedures that may require neutralization and a second precipitation step; e.g., neutralization of perchioric acid with KOH yields potassium perchiorate, which is insoluble. These additional steps may affect both the precision and accuracy of the assays. Third, the neutralization procedure may render the sample temporarily alkaline. The alkaline sample may require back-titration, increasing the number of steps even more. In addition, in an alkaline environment, some metabolites, e.g., ammonia, may be lost. Fourth, because SSA is neither an oxidizing nor a reducing agent, it is therefore suitable for measuring the concentration of such substances as glutathione, which exist in both reduced and oxidized forms (30). Oxidizing agents such as perchioric acid and picric acid clearly are unsuitable for such measurements. For example, perchloric acid converts reduced glutathione to its oxidized form (31); indeed, when 100 mL/L perchioric acid reagent is used to precipitate protein in whole blood at a ratio of 3/1 (by vol), nearly all the glutathione is found in the oxidized form (Khan and Elia, unpublished). 
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A drawback of using SSA in reactions linked with NADH (peak absorbance 340 nni) is that SSA absorbs substantially at 340 nm. Measurement at higher wavelengths reduces or abolishes this problem, but also reduces the sensitivity of the assay (by about 20% at 355 mu). Furthermore, incorrect calibration of spectrophotometers is more likely to cause inaccuracies when the wavelength used is on the steep part of an absorbance curve (Figure 1 ) than for wavelengths at the peak. 
Nevertheless

